Da Forno et al. demonstrated differential expression of WNT5A protein during melanoma progression, i.e., high expression of WNT5A in nevi, decreased expression during RGP, followed by an increase in WNT5A expression in VGP and in metastatic lesions [68]. The gene discussed is WNT5A; the disease is melanoma.